SCHEMBL7979883

SCHEMBL7979883

Cc1cc(Nc2nc3ccccc3n3cncc23)ccc1Cl

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.69
MEN1 O00255 1/20 0.56
NPC1 O15118 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969675 0.86 LCK (0.69) LCKNPC1KMT2A
SCHEMBL7980295 0.84 LCK (0.62) LCKNPC1KMT2A
SCHEMBL7983172 0.83 LCK (0.71) LCK
SCHEMBL7981428 0.83 LCK (0.80) LCK
SCHEMBL7979997 0.82 LCK (0.73) LCK
SCHEMBL7981469 0.81 LCK (1.00) LCKNPC1
SCHEMBL7979597 0.81 LCK (0.83) LCKNPC1
SCHEMBL7987291 0.81 LCK (1.00) LCK
SCHEMBL7969709 0.80 LCK (1.00) LCK
SCHEMBL4931040 0.80 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed